139x Filetype PDF File size 0.08 MB Source: cdn.mdedge.com
Practice Trends RHEUMATOLOGY NEWS • March 2005 50 Medicare May Cover Diet, Lifestyle Programs BY JOYCE FRIEDEN coronary artery disease and compared of the effect we’re observing is simply re- the Ornish program for heart disease pre- Associate Editor, Practice Trends them with 139 controls. Although no pa- gression to the mean?” he asked. vention in 2002. tients in the intervention group had had a Dr. Ornish admitted that there was More than 400 patients, average age 56, BALTIMORE — There might not have recent cardiac event, 55% had had a prior some regression but added, “there is a di- have participated, with a 90% completion been thunderous applause at last month’s myocardial infarction, compared with 28% rect correlation between degree of ad- rate, Mr. Lambert said. “They collective- meeting of the Medicare Coverage Advi- of controls. herence and outcomes at 1 year.” ly reduced their risk of a cardiac event by sory Committee, but the quiet approval The researchers found that after 3 years, Adherence was a concern for several 50% as measured by the ATP Framingham was quite enough for Dean Ornish, M.D. 77% of intervention patients who met in- panel members who wondered whether risk tool, and lowered their LDL by 21%.” The committee, which advises Medicare surance company criteria to undergo by- patients could really keep up with strict He noted that the average cost of the be- on coverage issues, voted to recommend pass or angioplasty were able to avoid it, regimens such as Dr. Ornish’s. havioral management program was $5,700, that Medicare cover the use of physician- saving Mutual of Omaha $30,000 per pa- But Dr. Ornish said he was merely ask- compared with the average cost of heart supervised intensive diet and lifestyle tient, Dr. Ornish reported. ing for these types of programs to be treat- surgery, which ranges from $57,000 to change programs for preventing and re- He admitted that his program requires a ed the same way as other interventions. $67,000. “By avoiding one procedure, it pays versing heart disease—programs such as lot of commit- for 10 members to complete the program.” the one developed by Dr. Ornish. ment. For the The committee also heard from Alex “I’m pleased by the opportunity to have first few months, Clark, Ph.D., of the University of Alber- all the evidence considered,” he said after participants at- ta’s Centre for Health Evidence in Ed- the panel approved the recommendation, tend two 4-hour monton. The Centers for Medicare and adding that he hoped that the evidence sessions, each Medicaid Services contracted with Dr. was compelling enough for Medicare to consisting of ex- Clark’s center to review outcomes studies make this type of lifestyle intervention a ercise, medita- for patients with symptomatic coronary part of its benefits package. tion or other artery disease undergoing one of three Medicare is not obligated to accept the stress reduction, types of therapy: cardiac rehabilitation recommendation of its advisory commit- a support group (group education and counseling only), tee. meeting, and a comprehensive cardiac rehabilitation Dr. Ornish, president of the Preventive lunch/lecture. (such as Dr. Ornish’s program, which in- Medicine Research Institute, Sausalito, Later, they de- cludes exercise in addition to group edu- Calif., outlined his program, which con- crease to once- cation and counseling), and individual sists of putting patients on a very low-fat weekly sessions, EEcounseling. All studies had to have out- diet (about 10% fat), getting them on a but continue for E. Lcomes for at least 50 patients to be in- moderate exercise program, teaching 9 months. cluded in the review. them stress management techniques such In a payment IVIANThe reviewers found that all three types V as stretching and meditation, and enrolling demonstration Many insurers pay for statins even though patients go off the of programs had some long-term benefits, them in support groups. project for drugs after a few months, Dr. Dean Ornish noted at the meeting. including reductions in mortality and hos- In a 1-year study of 28 patients who Medicare, Dr. pitalization, and improved quality of life, took part in the program and 20 controls, Ornish found that patients’ body weight “We will pay for bypass surgery and an- Dr. Clark said. “The foundation for change he found that the average percentage di- decreased both at 12 weeks and at 1 year. gioplasty, but diet and lifestyle interven- is happening at 12 months.” ameter stenosis regressed from 40% to He noted that the primary determinant tions, Medicare generally doesn’t pay for Information on program costs was 37.8% in the experimental group, com- of how much patients improved on the it,” he said, adding that many insurers pay sketchier, he noted. Only 6 out of 41 stud- pared with an average progression from program was adherence. “The more peo- for cholesterol-lowering statin drugs even ies mentioned costs, and three of those 42.7% to 46.1% in the control group. ple changed, the better they got,” he said. though studies have shown that patients “reported or implied” cost savings without In addition, there was a 91% reduction Advisory committee members ex- go off the drugs after a few months be- giving any relevant data. Most of the stud- in angina in the intervention group, com- pressed several concerns about Dr. Or- cause they don’t like the side effects. ies were heavy on male participants, with pared with a 165% increase in the control nish’s results. Also testifying were spokesmen from seven studies having no women at all. group. Clifford Goodman, Ph.D., a senior sci- two Blue Cross Blue Shield plans—Moun- In the end, panel members generally Dr. Ornish also investigated whether entist with the Lewin Group, a Falls tain State in West Virginia and Highmark agreed that the Ornish program and sim- other providers could be trained to im- Church, Va., consulting firm, noted that in Pennsylvania—that pay patients to en- ilar interventions improved patients’ long- plement his program, so he set up demon- some of the improvements in the patient roll in the Ornish program. Both said term survival rates and quality of life, but stration projects in other sites with more groups started to reverse slightly after a their plans were happy with the clinical they were less certain that other providers than 2,000 patients. year, and speculated that many patients outcomes and the cost savings. would be able to successfully implement In the first project, funded by Mutual of may be self-selecting for the program at a David Lambert, vice president of health the program and that it could be easily Omaha, the researchers studied 194 pa- time when their weight and other negative services for Mountain State Blue Cross translated to Medicare patients, many of tients with angiographically documented indicators are at their peak. “How much Blue Shield, said his plan began covering whom have multiple chronic illnesses. ■ Benefit of Heart Failure Disease Management Scrutinized BY BRUCE JANCIN savings. According to our study, those promises may be recommendations was left to the physician’s discretion. Denver Bureau empty,” said Dr. Galbreath, vice chairman for clinical pro- Patients randomized to disease management survived grams in the department of medicine at the University an average of 76 days longer than controls over the course NEW ORLEANS — Participation in a disease man- of Texas, San Antonio. of 18 months of follow-up. However, their performance agement program for heart failure resulted in a moder- Prior studies which concluded that disease management on a standard 6-minute walking test wasn’t significantly ate survival benefit but no objective improvement in func- programs are both clinically effective and cost-effective were better than that of controls, and neither was their mean tional capacity, no reduction in health care utilization, and small, nonrandomized, and/or based upon relatively ho- left ventricular ejection fraction. The disease management no cost savings in the largest and most rigorous study to mogeneous HMO populations. program did not reduce hospitalizations, office or ER vis- date of any disease management program. Recognition of these deficiencies provided the impetus its, procedures, or medications. The lack of demonstrable cost savings is a key finding. for the South Texas Congestive Heart Failure Disease Man- Subgroup analysis suggested the survival benefit was Disease management is a trendy public policy issue now, agement Project, in which 1,069 patients with systolic or greatest in patients with New York Heart Association class with Medicare and many state Medicaid programs ac- diastolic heart failure were randomized 2:1 to a disease man- III and IV systolic heart failure. But even in these patients tively pushing disease management programs for de- agement program or usual care and followed for 18 months, with more severe heart failure, disease management did pression, diabetes, and other chronic diseases as a means she explained. not result in economic savings. of saving money, Autumn Dawn Galbreath, M.D., ob- Subjects in the disease management group were assigned “If you factor in the cost of having to pay for the dis- served at the annual scientific sessions of the American a nurse case manager who provided in-depth patient edu- ease management services, disease management actual- Heart Association. cation and recommended medication changes in accord ly costs money over and above the cost of traditional “There’s a great deal of money being spent on disease with national heart failure guidelines to the patient’s pri- care,” Dr. Galbreath said. The investigators plan to ana- management at this time in anticipation of promised cost mary care physician, although whether or not to follow the lyze the data further to obtain cost-benefit ratios. ■
no reviews yet
Please Login to review.